There are 2789 resources available
710P - Comprehensive genomic profiling (CGP) of small cell neuroendocrine carcinoma of the bladder (NEBC)
Presenter: Andrea Necchi
Session: ePoster Display
711P - Outcomes according to genomic characteristics of patients with metastatic urothelial carcinoma in phase I/II trials
Presenter: Cedric Pobel
Session: ePoster Display
712P - Analysis of fibroblast growth factor receptor 3 aberrations in bladder cancer, for enabling personalized and effective therapy based on FGFR inhibitor
Presenter: Roman Sosnowski
Session: ePoster Display
713P - Assessment of bleomycin pulmonary toxicity in men with poor-prognosis non-seminomatous germ-cell tumors treated in the GETUG 13 phase III trial
Presenter: Natacha Naoun
Session: ePoster Display
714P - Prognostic factors in stage I seminoma: Data from the phase III, randomised TRial of Imaging and Surveillance in Seminoma Testis (TRISST)
Presenter: Elizabeth James
Session: ePoster Display
758P - Concordance between multiple HRD assays is substantial in high-grade ovarian cancer
Presenter: Wilko Weichert
Session: ePoster Display
759P - Adding dosing of plasmid encoding p62/SQSTM1 to gemcitabine chemotherapy may provide clinical benefits to patients with platinum-resistant ovarian cancer
Presenter: Sergey Polyakov
Session: ePoster Display
760P - Straightforward molecular tests for predicting response and non-response to platinum-based neoadjuvant therapy in high-grade serous ovarian cancer patients
Presenter: Evgeny Imyanitov
Session: ePoster Display
761P - Impact of residual disease on outcomes in patients with ovarian cancer: A meta-analysis
Presenter: Dana Chase
Session: ePoster Display